First‐in‐Human Single‐Ascending‐Dose, Multiple‐Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy

por Tiecke, Eva, Rainisio, Maurizio, Guentert, Theodor, Müller, Stephan, Hochman, Liat, Kaplan, Eli, Mangialaio, Sara
Publicado 2022

NRD.E1, an innovative non‐opioid therapy for painful diabetic peripheral neuropathy—A randomized proof of concept study

por Tiecke, Eva, Rainisio, Maurizio, Eisenberg, Elon, Wainstein, Julio, Kaplan, Eli, Silverberg, Michal, Hochman, Liat, Mangialaio, Sara
Publicado 2022

Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies

por Ratner, Paul, Andrews, Charles P., Hampel, Frank C., Martin, Bruce, Mohar, Dale E., Bourrelly, Denis, Danaietash, Parisa, Mangialaio, Sara, Dingemanse, Jasper, Hmissi, Abdel, van Bavel, Jay
Publicado 2017